TREATMENT OUTCOME OF CHEMOTHERAPY AND ANTIRETROVIRAL THERAPY AND COTRIMOXAZOLE PREVENTIVE THERAPY IN TUBERCULOSIS PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS COINFECTION

Objective: In developing countries like India, the fatality rate of tuberculosis (TB) coinfected with human immunodeficiency virus (HIV) is still at high and imposes significant challenge among physicians. The present study was conducted to evaluate management outcomes combined antiretroviral therapy (ART) chemotherapy or cotrimoxazole preventive (CPT) in TB/HIV co-infected patients. Methods: on 3512 confirmed TB patients who were treated ART CPT therapy. Out these, HIV positive 58 cases negative 3414 cases. algorithm KHB- Statpak- Unigold used. Patient started CPT. Results: Percentage coinfection greater 20–40-year age groups 2 times higher PTB sputum-positive Among extrapulmonary cases, 76% took + ART. treatment success 86%. Conclusion: Thus, must be established all centers compulsory screening implicated throughout country.